130 related articles for article (PubMed ID: 19913246)
1. Validation of the partin nomogram for prostate cancer in a national sample.
Yu JB; Makarov DV; Sharma R; Peschel RE; Partin AW; Gross CP
J Urol; 2010 Jan; 183(1):105-11. PubMed ID: 19913246
[TBL] [Abstract][Full Text] [Related]
2. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
3. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
Makarov DV; Trock BJ; Humphreys EB; Mangold LA; Walsh PC; Epstein JI; Partin AW
Urology; 2007 Jun; 69(6):1095-101. PubMed ID: 17572194
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
[TBL] [Abstract][Full Text] [Related]
5. Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis.
Jeong CW; Jeong SJ; Hong SK; Lee SB; Ku JH; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE
Int J Urol; 2012 Sep; 19(9):846-52. PubMed ID: 22587373
[TBL] [Abstract][Full Text] [Related]
6. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
Blute ML; Bergstralh EJ; Partin AW; Walsh PC; Kattan MW; Scardino PT; Montie JE; Pearson JD; Slezak JM; Zincke H
J Urol; 2000 Nov; 164(5):1591-5. PubMed ID: 11025711
[TBL] [Abstract][Full Text] [Related]
7. External validation of the updated Partin tables in a cohort of North American men.
Karakiewicz PI; Bhojani N; Capitanio U; Reuther AM; Suardi N; Jeldres C; Pharand D; Péloquin F; Perrotte P; Shariat SF; Klein EA
J Urol; 2008 Sep; 180(3):898-902; discussion 902-3. PubMed ID: 18635222
[TBL] [Abstract][Full Text] [Related]
8. Are Partin tables suitable for Chinese patients with prostate cancer?
Shen XC; Qiu YQ; Zheng YC; Zhang SZ
Chin Med J (Engl); 2012 Nov; 125(21):3795-9. PubMed ID: 23106876
[TBL] [Abstract][Full Text] [Related]
9. Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
Zorn KC; Capitanio U; Jeldres C; Arjane P; Perrotte P; Shariat SF; Lee DI; Shalhav AL; Zagaja GP; Shikanov SA; Gofrit ON; Thong AE; Albala DM; Sun L; Karakiewicz PI
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1461-7. PubMed ID: 18938046
[TBL] [Abstract][Full Text] [Related]
10. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
Gupta RT; Faridi KF; Singh AA; Passoni NM; Garcia-Reyes K; Madden JF; Polascik TJ
Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
[TBL] [Abstract][Full Text] [Related]
11. Predictive ability of partin tables 2001 in a Welsh population.
Ayyathurai R; Ananthakrishnan K; Rajasundaram R; Knight RJ; Toussi H; Srinivasan V
Urol Int; 2006; 76(3):217-22. PubMed ID: 16601382
[TBL] [Abstract][Full Text] [Related]
12. Validation of 2001 Partin tables in Turkey: a multicenter study.
Eskicorapci SY; Karabulut E; Türkeri L; Baltaci S; Cal C; Toktas G; Akpinar H; Ozer G; Sozen S; Tokuc R; Lekili M; Soylu A; Albayrak S; Sahin H; Alpar R; Ozen H
Eur Urol; 2005 Feb; 47(2):185-9. PubMed ID: 15661412
[TBL] [Abstract][Full Text] [Related]
13. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.
Penson DF; Grossfeld GD; Li YP; Henning JM; Lubeck DP; Carroll PR
J Urol; 2002 Apr; 167(4):1653-7; discussion 1657-8. PubMed ID: 11912382
[TBL] [Abstract][Full Text] [Related]
14. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.
Partin AW; Mangold LA; Lamm DM; Walsh PC; Epstein JI; Pearson JD
Urology; 2001 Dec; 58(6):843-8. PubMed ID: 11744442
[TBL] [Abstract][Full Text] [Related]
15. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.
Augustin H; Eggert T; Wenske S; Karakiewicz PI; Palisaar J; Daghofer F; Huland H; Graefen M
J Urol; 2004 Jan; 171(1):177-81. PubMed ID: 14665871
[TBL] [Abstract][Full Text] [Related]
16. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.
Eifler JB; Feng Z; Lin BM; Partin MT; Humphreys EB; Han M; Epstein JI; Walsh PC; Trock BJ; Partin AW
BJU Int; 2013 Jan; 111(1):22-9. PubMed ID: 22834909
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
[TBL] [Abstract][Full Text] [Related]
18. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
Sandeman K; Eineluoto JT; Pohjonen J; Erickson A; Kilpeläinen TP; Järvinen P; Santti H; Petas A; Matikainen M; Marjasuo S; Kenttämies A; Mirtti T; Rannikko A
PLoS One; 2020; 15(7):e0235779. PubMed ID: 32645056
[TBL] [Abstract][Full Text] [Related]
19. Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.
Huang Y; Isharwal S; Haese A; Chun FK; Makarov DV; Feng Z; Han M; Humphreys E; Epstein JI; Partin AW; Veltri RW
BJU Int; 2011 May; 107(10):1562-9. PubMed ID: 20875091
[TBL] [Abstract][Full Text] [Related]
20. Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?
Gupta RT; Brown AF; Silverman RK; Tay KJ; Madden JF; George DJ; Polascik TJ
AJR Am J Roentgenol; 2016 Jul; 207(1):87-95. PubMed ID: 27064383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]